Q2 2025 Clover Health Investments Corp Earnings Call Transcript

Aug 5, 2025 / 09:00 PM GMT

Release Date Price: €2.49 (-0.32%)

Transcript 10-Q8-K

Key Points

Positve

Clover Health Investments Corp (CLOV) reported significant membership growth of over 30% year-over-year, surpassing industry averages.
The company achieved sustained adjusted profitability in Medicare Advantage, demonstrating effective execution of its strategy.
Clover Health's technology-first care model, including the Clover Assistant, has shown to improve health outcomes, such as reducing hospitalizations and readmissions for chronic diseases.
The company is well-positioned for future growth with a four-star payment year in 2026, providing a financial tailwind.
Clover Health is expanding its technology platform to other risk-bearing entities, showing broad interest and uptake, which could drive additional revenue streams.

Negative

Clover Health is experiencing elevated cost trends within its Medicare Advantage book, similar to broader industry pressures.
The company is facing variability in modeling performance due to the new Part D IRA changes, which could impact financial results.
There are elevated pockets of utilization within supplemental benefits and Part B, which negatively impacted results.
The competitive landscape remains challenging, with national players pulling back in certain areas, potentially affecting market dynamics.
Clover Health's insurance benefit expense ratio (BER) increased year-over-year, reflecting higher costs and impacting profitability.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CLOV.OQ - Clover Health Investments Corp
Q2 2025 Clover Health Investments Corp Earnings Call
Aug 05, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
If you all say on hold. We appreciate your patience and ask that you please continue to stand by. Your program will begin momentarily.

.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Please stand by. Your program is about to begin.

Ladies and gentlemen, good afternoon and welcome to the Clover Health 2nd quarter 2025 earnings conference call.

At this time, all participants are in a listen-only mode.

A question and answer session will follow the prepared remarks. At that time, if you would like to ask a question, please

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.